AHPA Seeks Ephedra Rule Stay For Traditional Herbs Labeled As Supplements
This article was originally published in The Tan Sheet
Executive Summary
AHPA has petitioned the FDA to stay its ephedra ban "only insofar as it pertains to traditional herbal formulas" marketed to licensed health care practitioners
You may also be interested in...
AHPA Modifies Ephedra Petition To Specify Two Chinese Herbals
The American Herbal Products Association is modifying a petition to stay FDA's ephedra ban by highlighting two Chinese herbal ingredients that the group feels are wrongly included
AHPA Modifies Ephedra Petition To Specify Two Chinese Herbals
The American Herbal Products Association is modifying a petition to stay FDA's ephedra ban by highlighting two Chinese herbal ingredients that the group feels are wrongly included
AHPA Modifies Ephedra Petition To Specify Two Chinese Herbals
The American Herbal Products Association is modifying a petition to stay FDA's ephedra ban by highlighting two Chinese herbal ingredients that the group feels are wrongly included